Showing 2,402 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP

HIV drug research in Wales to cut infection risk

Editor's pick
BBC
16 August 2018
New & experimental HIV treatments

ViiV, Janssen’s two-drug HIV regimen hits PhIII targets

Editor's pick
Pharma Times
15 August 2018
Treatment for women

Lynne Mofenson, M.D., Explains the Dolutegravir Risks for People With HIV Who Want to Get Pregnant

Editor's pick
The Body PRO
15 August 2018
New & experimental HIV treatments

How Will Long-Acting HIV Antiretrovirals Work in the Real World?

Editor's pick
The Body Pro
1 August 2018
Undetectable viral load & treatment as prevention

Australian doctors to tell HIV patients that 'undetectable=untransmissible'

Editor's pick
Gay Star News
24 July 2018
New & experimental HIV treatments

The 2018 Pipeline Report

Editor's pick
TAG
24 July 2018
HIV treatment

Benefits, Risks of Dolutegravir Center Stage at AIDS 2018

Editor's pick
Medscape (requires free registration)
18 July 2018
New & experimental HIV treatments

FDA approves Janssen's HIV combination Symtuza

Editor's pick
Pharmaphorum
18 July 2018
Drug interactions & pharmacokinetics

Darunavir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1

Editor's pick
MHRA
18 July 2018
Pharmaceutical industry

Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug

Editor's pick
Seeking Alpha
18 July 2018
Retention & linkage to care

TAC: ARV treatment education best way to bring down HIV infection rates

Editor's pick
Eyewitness News
18 July 2018
PrEP

Reported 'PrEP Failure' in Thailand May Be a Missed Acute HIV Infection: Here's What You Need to Know

Editor's pick
TheBody PRO
17 July 2018
New & experimental HIV treatments

CytoDyn Announces Positive Results from Completed Pivotal PRO 140 HIV Combination Trial

Editor's pick
CytoDyn press release
17 July 2018
Pregnancy and vertical transmission

Dolutegravir preconception signal: time is up for shoddy surveillance

Editor's pick
HIV i-Base
16 July 2018
Adherence

Blood, Hair, or Urine? Weighing PrEP Adherence Options Beyond Self-Report

Editor's pick
The Body Pro
16 July 2018
Side effects

We Must Talk About Having Diarrhea. I’ll Go First.

Editor's pick
My Fabulous Disease
16 July 2018
Pregnancy and vertical transmission

Dolutegravir: need to consider all pros and cons before switching in pregnancy

Editor's pick
HIV i-Base
11 July 2018
HIV treatment

Reduced-Dose Darunavir Effective in Virologically Suppressed HIV-1

Editor's pick
Infectious Disease Advisor
4 July 2018
New & experimental HIV treatments

Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection

Editor's pick
Abivax press release
4 July 2018
People & personal stories

Nelson Vergel: Built to Survive

Editor's pick
Poz
29 June 2018
HIV prevention policy

'New York Times' To Condoms: Drop Dead

Editor's pick
HIV Plus
29 June 2018
Epidemiology & behaviour

Dispelling the Bad Myths about PrEP in that New York Times Op-Ed

Editor's pick
Jezebel
27 June 2018
Side effects

No association found between efavirenz, suicide risk

Editor's pick
Healio
26 June 2018
New & experimental HIV treatments

European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
25 June 2018